Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Intra-Cellular Therapies, Inc.Financial_Report.xls
10-K - FORM 10-K - Intra-Cellular Therapies, Inc.d675342d10k.htm
EX-31.2 - EX-31.2 - Intra-Cellular Therapies, Inc.d675342dex312.htm
EX-31.1 - EX-31.1 - Intra-Cellular Therapies, Inc.d675342dex311.htm
EX-10.8 - EX-10.8 - Intra-Cellular Therapies, Inc.d675342dex108.htm
EX-23.1 - EX-23.1 - Intra-Cellular Therapies, Inc.d675342dex231.htm
EX-10.19 - EX-10.19 - Intra-Cellular Therapies, Inc.d675342dex1019.htm
EX-10.14 - EX-10.14 - Intra-Cellular Therapies, Inc.d675342dex1014.htm

Exhibit 32.1

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report for the year ended December 31, 2013 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: March 25, 2014   /s/ Sharon Mates, Ph.D.
 

Sharon Mates, Ph.D.

 

Chairman, President and Chief Executive Officer

(principal executive officer)

 

Dated: March 25, 2014                /s/ Lawrence J. Hineline
 

Lawrence J. Hineline

 

Vice President of Finance, Chief Financial Officer and

Secretary

(principal financial officer and principal accounting officer)